Brahe, Cristina Beate
 Distribuzione geografica
Continente #
NA - Nord America 509
EU - Europa 479
AS - Asia 141
AF - Africa 1
Totale 1.130
Nazione #
US - Stati Uniti d'America 508
DE - Germania 215
CN - Cina 89
SE - Svezia 78
UA - Ucraina 67
IE - Irlanda 25
IT - Italia 22
SG - Singapore 21
FI - Finlandia 20
FR - Francia 15
IN - India 15
GB - Regno Unito 10
RU - Federazione Russa 10
TR - Turchia 10
PL - Polonia 7
NL - Olanda 5
HK - Hong Kong 4
AT - Austria 2
CA - Canada 1
CH - Svizzera 1
CI - Costa d'Avorio 1
HU - Ungheria 1
IR - Iran 1
JP - Giappone 1
LV - Lettonia 1
Totale 1.130
Città #
Chandler 132
Ashburn 38
Jacksonville 34
San Mateo 28
Dublin 25
Nanjing 23
Woodbridge 21
Wilmington 17
Nürnberg 14
Singapore 14
Bremen 13
Dearborn 13
Detroit 12
Munich 12
Boston 11
Lawrence 11
Nanchang 11
Houston 10
Beijing 9
Fairfield 9
Seattle 9
Moscow 8
Ann Arbor 7
Boardman 7
Helsinki 7
Shenyang 7
Changsha 6
Izmir 6
Kraków 6
New York 6
Kunming 5
Los Angeles 5
Zhengzhou 5
Hebei 4
Kocaeli 4
Milan 4
Mountain View 4
Cambridge 3
Hangzhou 3
Tianjin 3
University Park 3
Cattolica 2
Central District 2
Changchun 2
Colico 2
Guangzhou 2
Hong Kong 2
Jiaxing 2
Leawood 2
Ningbo 2
Norwalk 2
Princeton 2
Prineville 2
Redwood City 2
Taizhou 2
Abidjan 1
Amsterdam 1
Augusta 1
Bern 1
Buffalo 1
Busto Arsizio 1
Cincinnati 1
Costa Mesa 1
Dallas 1
Falkenstein 1
Ferrero 1
Fort Worth 1
Indiana 1
London 1
Marseille 1
Mumbai 1
Oggiono 1
Old Bridge 1
Philadelphia 1
Riga 1
Rome 1
San Francisco 1
San Jose 1
Santa Clara 1
Simi Valley 1
Springfield 1
Toronto 1
Xian 1
Totale 625
Nome #
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 121
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 115
Biomarkers in rare disorders: the experience with spinal muscular atrophy 102
Salbutamol increases serviva motor neuron (SMN) patients: relevance for clinical trial design 97
The complex interaction between APOE promoter and AD: an Italian case-control study 91
INCREASED LEVELS OF GLIAL CELL-DERIVED NEUROTROPHIC FACTOR IN CSF OF INFANTS WITH SMA 91
Deletions in the SMN gene in infantile and adult spinal muscular atrophy patients from the same family 89
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. 85
Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells 83
Detection of the survival motor neuron (SMN) genes by FISH: Further evidence for a role for SMN2 in the modulation of disease severity in SMA patients 62
SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis 60
Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I 58
Refined characterization of the expression and stability of the SMN gene products 53
Allelic distribution of apolipoprotein E (ApoE) and ApoE promoter polymorphisms in patients with frontotemporal dementia. 13
Analysis of allelic distribution of ApoE promoter polymorphism: relation to gender, age at onset, and var epsilon epsilon 4 in a sample of sporardic AD patients. 12
Apoe epsilon2-epsilon4 genotype is a possible risk factor for prymary progressive aphasia 2
Totale 1.134
Categoria #
all - tutte 4.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 6 3 6 8 5 22 5 7 5 24 14
2020/2021130 3 13 3 13 18 3 26 3 16 11 21 0
2021/2022101 5 13 1 8 2 3 0 14 6 3 15 31
2022/2023303 31 47 17 64 21 39 5 25 33 3 11 7
2023/2024120 5 43 11 18 2 3 5 2 2 0 12 17
2024/202511 6 5 0 0 0 0 0 0 0 0 0 0
Totale 1.134